Nomograms predicting extra- and early intrahepatic recurrence after hepatic resection of hepatocellular carcinoma.


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
04 2021
Historique:
received: 01 06 2020
revised: 02 10 2020
accepted: 14 10 2020
pubmed: 17 11 2020
medline: 1 5 2021
entrez: 16 11 2020
Statut: ppublish

Résumé

Extrahepatic recurrence and early intrahepatic recurrence of hepatocellular carcinoma after hepatic resection are indicative of poor prognoses. We aimed to develop nomograms to predict extrahepatic recurrence and early intrahepatic recurrence after hepatic resection. The participants of this study were 1,206 patients who underwent initial and curative hepatic resection for hepatocellular carcinoma. Multivariate logistic regression analyses using the Akaike information criterion were used to construct nomograms to predict extrahepatic recurrence and early intrahepatic recurrence (within 1 year of surgery) at the first recurrence sites after hepatic resection. Performance of each nomogram was evaluated by calibration plots with bootstrapping. Extrahepatic recurrence was identified in 95 patients (7.9%) and early intrahepatic recurrence in 296 patients (24.5%). Three predictive factors, α-fetoprotein >200 ng/mL, tumor size (3-5 cm or >5 cm vs ≤3 cm), and image-diagnosed venous invasion by computed tomography, were adopted in the final model of the extrahepatic recurrence nomogram with a concordance index of 0.75. Tumor size and 2 additional predictors (ie, multiple tumors and image-diagnosed portal invasion) were adopted in the final model of the early intrahepatic recurrence nomogram with a concordance index of 0.67. The calibration plots showed good agreement between the nomogram predictions of extrahepatic recurrence and early intrahepatic recurrence and the actual observations of extrahepatic recurrence and early intrahepatic recurrence, respectively. We have developed reliable nomograms to predict extrahepatic recurrence and early intrahepatic recurrence of hepatocellular carcinoma after hepatic resection. These are useful for the diagnostic prediction of extrahepatic recurrence and early intrahepatic recurrence and could guide the surgeon's selection of treatment strategies for hepatocellular carcinoma patients.

Sections du résumé

BACKGROUND
Extrahepatic recurrence and early intrahepatic recurrence of hepatocellular carcinoma after hepatic resection are indicative of poor prognoses. We aimed to develop nomograms to predict extrahepatic recurrence and early intrahepatic recurrence after hepatic resection.
METHODS
The participants of this study were 1,206 patients who underwent initial and curative hepatic resection for hepatocellular carcinoma. Multivariate logistic regression analyses using the Akaike information criterion were used to construct nomograms to predict extrahepatic recurrence and early intrahepatic recurrence (within 1 year of surgery) at the first recurrence sites after hepatic resection. Performance of each nomogram was evaluated by calibration plots with bootstrapping.
RESULTS
Extrahepatic recurrence was identified in 95 patients (7.9%) and early intrahepatic recurrence in 296 patients (24.5%). Three predictive factors, α-fetoprotein >200 ng/mL, tumor size (3-5 cm or >5 cm vs ≤3 cm), and image-diagnosed venous invasion by computed tomography, were adopted in the final model of the extrahepatic recurrence nomogram with a concordance index of 0.75. Tumor size and 2 additional predictors (ie, multiple tumors and image-diagnosed portal invasion) were adopted in the final model of the early intrahepatic recurrence nomogram with a concordance index of 0.67. The calibration plots showed good agreement between the nomogram predictions of extrahepatic recurrence and early intrahepatic recurrence and the actual observations of extrahepatic recurrence and early intrahepatic recurrence, respectively.
CONCLUSION
We have developed reliable nomograms to predict extrahepatic recurrence and early intrahepatic recurrence of hepatocellular carcinoma after hepatic resection. These are useful for the diagnostic prediction of extrahepatic recurrence and early intrahepatic recurrence and could guide the surgeon's selection of treatment strategies for hepatocellular carcinoma patients.

Identifiants

pubmed: 33190917
pii: S0039-6060(20)30693-0
doi: 10.1016/j.surg.2020.10.012
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

922-928

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Hiroji Shinkawa (H)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Japan. Electronic address: m1297198@msic.med.osaka-cu.ac.jp.

Shogo Tanaka (S)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Japan.

Shigekazu Takemura (S)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Japan.

Ryosuke Amano (R)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Japan.

Kenjiro Kimura (K)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Japan.

Masahiko Kinoshita (M)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Japan.

Kanae Takahashi (K)

Department of Medical Statistics, Osaka City University Graduate School of Medicine, Japan.

Shuichiro Matsuzaki (S)

Osaka City University Faculty of Medicine, Japan.

Shoji Kubo (S)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH